Tyra Biosciences (TYRA) Common Equity (2020 - 2026)
Quarterly Common Equity rose 19.79% to $387.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $387.6 million through Mar 2026, up 19.79% year-over-year, with the annual reading at $259.2 million for FY2025, 24.47% down from the prior year.
Tyra Biosciences filings provide 7 years of Common Equity readings, the most recent being $387.6 million for Q1 2026.
- Common Equity hit $387.6 million in Q1 2026 for Tyra Biosciences, up from $259.2 million in the prior quarter.
- Across five years, Common Equity topped out at $389.9 million in Q1 2024 and bottomed at $204.3 million in Q4 2023.
- Average Common Equity over 5 years is $296.1 million, with a median of $280.5 million recorded in 2025.
- The largest annual shift saw Common Equity soared 1761.82% in 2022 before it decreased 24.47% in 2025.
- Tyra Biosciences' Common Equity stood at $257.8 million in 2022, then fell by 20.78% to $204.3 million in 2023, then skyrocketed by 68.0% to $343.2 million in 2024, then dropped by 24.47% to $259.2 million in 2025, then surged by 49.54% to $387.6 million in 2026.
- Per Business Quant, the three most recent readings for TYRA's Common Equity are $387.6 million (Q1 2026), $259.2 million (Q4 2025), and $280.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Tyra Biosciences | 2.03 Bn | 2.03 Bn | - | 387.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 387.58 Mn |
| Dec 31, 2025 | 259.18 Mn |
| Sep 30, 2025 | 280.51 Mn |
| Jun 30, 2025 | 302.15 Mn |
| Mar 31, 2025 | 323.53 Mn |
| Dec 31, 2024 | 343.15 Mn |
| Sep 30, 2024 | 362.29 Mn |
| Jun 30, 2024 | 376.04 Mn |
| Mar 31, 2024 | 389.88 Mn |
| Dec 31, 2023 | 204.26 Mn |
| Sep 30, 2023 | 222.17 Mn |
| Jun 30, 2023 | 238.57 Mn |
| Mar 31, 2023 | 248.79 Mn |
| Dec 31, 2022 | 257.83 Mn |
| Sep 30, 2022 | 267.76 Mn |
| Jun 30, 2022 | 278.85 Mn |
| Mar 31, 2022 | 291.18 Mn |
| Dec 31, 2021 | 301.74 Mn |
| Sep 30, 2021 | 309.73 Mn |
| Jun 30, 2021 | -22.67 Mn |
| Mar 31, 2021 | -17.52 Mn |
| Dec 31, 2020 | -13.64 Mn |
| Sep 30, 2020 | -10.08 Mn |